Key clinical point: Robotic bronchoscopy targeted lung nodules more effectively than did electromagnetic navigation or an ultrathin bronchoscope with radial endobronchial ultrasound (UTB-rEBUS).
Major finding: The study’s primary endpoint, which was the ability to localize and puncture target nodules within three attempts, was met in 25% of UTB-rEBUS procedures, 45% of electromagnetic navigation procedures, and 80% of robotic bronchoscopy procedures.
Study details: Prospective study of 60 procedures targeting 20 nodules implanted in cadavers
Disclosures: This study was funded by the Association of Interventional Pulmonary Program Directors. Dr. Yarmus disclosed government and societal funding and relationships with Boston Scientific, Veran, Medtronic, Intuitive, Auris, Erbe, Olympus, BD, Rocket, Ambu, Inspire Medical, and AstraZeneca.
Yarmus L et al. CHEST 2019. Abstract, doi: 10.1016/j.chest.2019.08.311.